Novel topically administrable pharmaceutical compositions
Patent 4917886 Issued on April 17, 1990. Estimated Expiration Date: 
August 21, 2009. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
August 21, 2009. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References 3629412 3749773 Antiinflammatory analgesic gelled ointment Topical combinations of an -estradiol with a methyl xanthine Antiinflammatory analgesic gelled ointment Pharmaceutical preparations for topical application which contain salts of alkanecarboxylic acids Paper roll towel dispenser Patent #: 4807824 InventorsAssigneeApplicationNo. 396781 filed on 08/21/1989US Classes:514/567, Benzene ring nonionically bonded424/78.05Anti-inflammatory or anti-irritant (e.g., anti-arthritic, etc.)ExaminersPrimary: Friedman, Stanley J.Attorney, Agent or FirmForeign Patent References
International ClassA61K 031/78Foreign Application Priority Data1982-10-07 CHAbstractNovel topically administrable pharamceutical composition containing, as active ingredient, from approximately 0.1 to approximately 10% by weight of a non-steroidal, anti-inflammatorially active compound having at least one acidic group, from approximately 10 to approximately 50% by weight of a water-soluble, volatile lower alkanol having from 2 up to and including 4 carbon atoms, from approximately 3 to approximately 15% by weight of an optionally self-emulsifying lipid or a mixture of lipids, from approximately 0.5 to approximately 2% by weight of a gel structure former, from approximately 1 to approximately 20% by weight of a co-solvent, from approximately 40 to approximately 80% by weight of water, optionally from approximately 0.5 to approximately 5% by weight of an emulsifier if the lipid phase is not self-emulsifying and, if desired, non-essential constituents.Other References
| |
